result 18181 件
JaLCDOI | 10.18926/AMO/31989 |
---|---|
FullText URL | fulltext.pdf |
Author | Ishii, Yasushi| Shimomura, Hiroyuki| Ito, Mamoru| Miyake, Masanobu| Ikeda, Fusao| Miyake, Jiro| Fujioka, Shin-ichi| Iwasaki, Yoshiaki| Tsuji, Hideyuki| Tsuji, Takao| |
Abstract | It has been documented that the serum complement activities measured by hemolytic assay (CH50) are decreased after storage of sera at a low temperature in some patients with chronic hepatitis C. However, the mechanism of this phenomenon has not been identified yet. Here, we tried to elucidate factors involved in the cold activation of complement (CAC). To clarify what pathway is activated in CAC, we measured complement cleavage products after cold storage of sera. C4d increased significantly after 12 h-storage at cold temperatures in 5 CAC (+) sera compared with 5 CAC (-) (P < 0.01) and 3 control sera (P < 0.05), while Bb did not increase in any of the groups. In order to determine whether IgG or IgG complex is necessary for CAC, 8 CAC (+) sera were incubated with Protein G Sepharose gel beads, and all of them retained hemolytic activities to some extent after cold storage. Column chromatography through Superose 6HR of CAC-positive serum identified the fractions containing molecules that induced CAC in normal serum, which were depleted by treatment with protein G Sepharose. In conclusion, CAC in hepatitis C seems to occur via a classical or lectin pathway, and the IgG complex produced in hepatitis C virus infection may be an important factor in inducing CAC, a common extrahepatic manifestation of hepatitis C. |
Keywords | hepatitis C virus chronic hepatitis complement activation |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2001-08 |
Volume | volume55 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 229 |
End Page | 235 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 11512565 |
Web of Science KeyUT | 000170367200005 |
JaLCDOI | 10.18926/AMO/31988 |
---|---|
FullText URL | fulltext.pdf |
Author | Tate, Genshu| Suzuki, Takao| Kishimoto, Koji| Mitsuya, Toshiyuki| |
Abstract | Mutations of the c-KIT gene have been reported not only in gastrointestinal stromal tumors and mast cell tumors, but also in testicular germ cell tumors (TGCTs). In the present study we employed polymerase chain reaction and DNA sequencing analysis to characterize the c-KIT gene in a 29-year-old Japanese patient with bilateral testicular seminomas. Direct sequence analyses revealed a single base substitution in exon 17 in one c-KIT allele, resulting in an amino acid substitution of D816H in this mutated allele. This mutation was found in the left, but not in the right, testicular seminoma. This is the first description of a c-KIT gene mutation in a Japanese patient with bilateral TGCT. The mutational analysis of the c-KIT gene seems to provide crucial information for managing TGCT patients not only in Europe but also in Japan. |
Keywords | testicular germ-cell tumor seminoma c-KIT CD117 |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-02 |
Volume | volume59 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 33 |
End Page | 36 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15902997 |
Web of Science KeyUT | 000227263300005 |
JaLCDOI | 10.18926/AMO/31987 |
---|---|
FullText URL | fulltext.pdf |
Author | Kawabata, Masahiro| Kawabata, Teruyuki| Nishibori, Masahiro| |
Abstract | DNA damage causes chromosomal instability leading to oncogenesis, apoptosis, and severe failure of cell functions. The DNA repair system includes base excision repair, nucleotide excision repair, mismatch repair, translesion replication, non-homologous end-joining, and recombinational repair. Homologous recombination performs the recombinational repair. The RAD51 gene is an ortholog of Esherichia coli recA, and the gene product Rad51 protein plays a central role in the homologous recombination. In mammals, 7 recA-like genes have been identified: RAD51, RAD51L1/B, RAD51L2/C, RAD51L3/D, XRCC2, XRCC3, and DMC1. These genes, with the exception of meiosis-specific DMC1, are essential for development in mammals. Disruption of the RAD51 gene leads to cell death, whereas RAD51L1/B, RAD51L2/C, RAD51L3/D, XRCC2, and XRCC3 genes (RAD51 paralogs) are not essential for viability of cells, but these gene-deficient cells exhibit a similar defective phenotype. Yeast two-hybrid analysis, co-immunoprecipitation, mutation analysis, and domain mapping of Rad51 and Rad51 paralogs have revealed protein-protein interactions among these gene products. Recent investigations have shown that Rad51 paralogs play a role not only in an early step, but also in a late step of homologous recombination. In addition, identification of alternative transcripts of some RAD51 paralogs may reflect the complexity of the homologous recombination system. |
Keywords | RAD51 RAD51 paralogs recA recombination DNA repair |
Amo Type | Review |
Publication Title | Acta Medica Okayama |
Published Date | 2005-02 |
Volume | volume59 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 1 |
End Page | 9 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15902993 |
Web of Science KeyUT | 000227263300001 |
JaLCDOI | 10.18926/AMO/31986 |
---|---|
FullText URL | fulltext.pdf |
Author | Ochiai, Hirotaka| Ohtsu, Tadahiro| Tsuda, Toshihide| Kagawa, Haruko| Kawashita, Toshiaki| Takao, Soshi| Tsutsumi, Akizumi| Kawakami, Norito| |
Abstract | On February 13, 2002, a public health center in Hiroshima Prefecture, Japan, was notified that many individuals living at the Japan Maritime Self-Defence Force base had symptoms resembling those of food poisoning. Self-administered questionnaires requesting information regarding meal consumption and symptoms were distributed to all 281 members at the base. A case of the illness was defined as a member who had had watery or mucousy stool, or loose stool with abdominal cramps, more than twice a day after consuming dinner on February 12. Control of the illness was defined as a member with no symptoms. The dinner on February 12 was significantly associated with the illness (Mantel-Haenszel odds ratio: 3.59, 95% confidence interval: 1.06-12.20). A case-control study showed that, among the food supplied at dinner on February 12, the braised chop suey was significantly associated with the illness (odds ratio: 12.30, 95% confidence interval: 1.90-521.00). The braised chop suey had been stored in a chafing dish. An environmental investigation indicated that Clostridium perfringens (C. perfringens) in the chafing dish proliferated under an inappropriate heat-retention temperature, and the contaminated braised chop suey could have caused the food poisoning. This study demonstrated that the recommended heat-retention temperature (over 65 degrees C) should be confirmed thoroughly. |
Keywords | outbreak Clostridium perfringens (C. perfringens) epidemiology food poisoning |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-02 |
Volume | volume59 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 27 |
End Page | 32 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15902996 |
Web of Science KeyUT | 000227263300004 |
JaLCDOI | 10.18926/AMO/31985 |
---|---|
FullText URL | fulltext.pdf |
Author | Camdeviren, Handan| Mendes, Mehmet| Ozkan, M. Muhip| Toros, Fevziye| Sasmaz, Tayyar| Oner, Seva| |
Abstract | We used a regression tree method (RTM) to determine risks of depression in children/adolescents. The survey records of 4,143 children/adolescents in a study based in Mersin, Turkey served as data in this study, and multi-step, stratified, and cluster sampling were used. Effects of 24 variables (sex, smoking, parental problems, etc.) were evaluated on depression scores. The Child Beck Depression Inventory (CBDI) was used to determine the level of depression. Subjects were into 12 different groups based on magnitudes of mean depression scores. The interactions among 7 variables determined to be risk factors are shown on a schema. The STATISTICA (ver.6.0) package program was used for all computations. Although traditional statistical methods have often been used for analysis in this field, such approaches are associated with certain disadvantages such as missing values, ignorance of interaction effects, or restriction of the shape of the distribution. To avoid such disadvantages, we therefore suggest the use of the RTM in studies involving numerical-based outcome variables and for the investigation of a large number of variables and it may be more effective than traditional statistical methods in epidemiological studies which determine risk factors. |
Keywords | children and adolescents Beck depression inventory classification and regression trees cross-yalidation diagnostic models |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-02 |
Volume | volume59 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 19 |
End Page | 26 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15902995 |
Web of Science KeyUT | 000227263300003 |
JaLCDOI | 10.18926/AMO/31984 |
---|---|
FullText URL | fulltext.pdf |
Author | Tikiz, Canan| Utuk, Ozan| Bayturan, Ozgur| Bayindir, Petek| Ekmekci, Cenk| Tikiz, Hakan| |
Abstract | In this study, we investigated the effects of both 25 and 50 mg daily doses of rofecoxib on the endothelial functions of patients with coronary artery disease (CAD). For this purpose, 34 patients with documented severe CAD and who were under aspirin treatment (300 mg/day) were randomized to receive 4 weeks of treatment with a placebo (n = 10, group I), rofecoxib 25 mg/day (n = 12, group II), and rofecoxib 50 mg/day (n = 12, group III). Brachial artery vasodilator responses were measured in order to evaluate endothelial function. The percentage of change in endothelial-dependent vasodilation in groups I, II, and III were similar at the baseline level and showed no significant change after treatment (6.2+/-3.9% vs. 5.9+/-3.1% and 5.8+/-3.3% vs. 5.6+/-3.8% and 6.1+/-4.5% vs. 5.8+/-4.1%, respectively; P > 0.05). Compared with the baseline, endothelium-independent vasodilatation, as assessed by nitroglycerine (NTG), remained unchanged after the treatment period (11.2+/-6.9% vs. 10.3+/-7.1% and 11.2+/-6.3% vs. 9.9+/-5.1% and 9.5+/-4.9% and 8.8+/-4.6%, respectively; P> 0.05). Treatment with both doses also showed no significant effects on high-sensitivity C-reactive protein (hs-CRP) levels and resting arterial diameters (P > 0.05). In conclusion, 4 weeks of treatment with standard and high doses of rofecoxib showed no significant effects on either endothelial-dependent or independent vasodilator response or plasma hs-CRP levels in patients with severe CAD taking concomitant aspirin. |
Keywords | cyclooxy genase-2inhibition endothelial function high-sensitivity C-reactive protein coronary artery disease |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-02 |
Volume | volume59 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 11 |
End Page | 17 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15902994 |
Web of Science KeyUT | 000227263300002 |
JaLCDOI | 10.18926/AMO/31980 |
---|---|
FullText URL | fulltext.pdf |
Author | Shinomiya, Kazuaki| Fujimura, Katsuyuki| Kim, Yonsu| Kamei, Chiaki| |
Abstract | The present study was performed to investigate the effects of valerian extract on the sleep-wake cycle using sleep-disturbed model rats. A significant shortening in sleep latency was observed with valerian extract at doses of 1000 and 3000 mg/kg. On the other hand, valerian extract had no significant effects on total times of wakefulness, non-rapid eye movement (non-REM) sleep, or REM sleep, even at a dose of 3000 mg/kg. Valerian extract at doses of 1000 and 3000 mg/kg showed a significant increase in the delta activity during non-REM sleep. In conclusion, valerian extract may be useful as an herbal medicine having not only sleep-inducing effects but also sleep quality-enhancement effects. |
Keywords | delta activity insomnia sleep latency sleep quality sleep-disturbed model valerian |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-06 |
Volume | volume59 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 89 |
End Page | 92 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049561 |
Web of Science KeyUT | 000230039100003 |
JaLCDOI | 10.18926/AMO/31979 |
---|---|
FullText URL | fulltext.pdf |
Author | Seno, Yuko| Kariyama, Reiko| Mitsuhata, Ritsuko| Monden, Koichi| Kumon, Hiromi| |
Abstract | The potential relationships between biofilm formation and pathogenicity of Enterococcus faecalis in urinary tract infections (UTI) were investigated. Over a 12-year period from 1991 through 2002, a total of 352 E.faecalis isolates were collected from patients with complicated UTI (one isolate per patient) at the urology ward of Okayama University Hospital. We analyzed the prevalence and transferability of genes encoding virulence factors(asa1, esp, cylA, gelE /sprE )and antimicrobial resistance(aac(6') /aph(2'')). The production of biofilm, hemolysin and gelatinase by these isolates was also examined and the associated medical records of patients were retrospectively reviewed. Of 352 E. faecalis isolates, 315 possessed and/or genes. Of the 63 hemolysin- and 167 gelatinase-producing isolates, 59 and 94 isolates, respectively, possessed both asa1 and esp genes. E. faecalis isolates with both asa1 and esp genes formed biofilms at significantly higher rates than those with neither gene (P=0.038). The genes encoding asa1, cylA , and aac(6') /(aph(2'') were transferable and appeared to have accumulated in these isolates. The E. faecalis isolates possessing asa1 and/or esp genes were found from both catheter-related or -unrelated UTI. Our study indicates that E. faecalis isolates that have accumulated virulence genes are apt to form persistent biofilms in the urinary tracts. |
Keywords | Enterococcus faecalis urinary tract infection biofilm formation pathogenicity gene transfer |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-06 |
Volume | volume59 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 79 |
End Page | 87 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049560 |
Web of Science KeyUT | 000230039100002 |
JaLCDOI | 10.18926/AMO/31978 |
---|---|
FullText URL | fulltext.pdf |
Author | Ozawa, Hideo| Nagai, Atsushi| Uematsu, Katsutoshi| Ohmori, Hiroyuki| Kumon, Hiromi| |
Abstract | We report a case in which retroperitoneoscopic pyelolithotomy was the procedure selected to treat a large stone in the upper urinary tract. A 71-year-old woman who had multiple cerebral infarction and dementia was admitted with a persistent high fever unresponsive to antibiotics. The diagnosis was pyelonephritis and urosepsis associated with ureteral calculus. A large calculus(3.0 x 2.0 cm)was found in the left ureter at the L3 level. She underwent nephrostomy of the left side. After the patient's general condition had improved, surgery was performed successfully with an uneventful recovery. The findings in this case confirm that retroperitoneoscopic surgery allows removal of a large stone in a single, minimally invasive procedures. |
Keywords | retroperitoneoscopic pyelolithotomy urinary stone laparoscopic surgery |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-06 |
Volume | volume59 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 109 |
End Page | 112 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049564 |
Web of Science KeyUT | 000230039100006 |
JaLCDOI | 10.18926/AMO/31977 |
---|---|
FullText URL | fulltext.pdf |
Author | Mikuniya, Takeshi| Kato, Yoshihisa| Kariyama, Reiko| Monden, Koichi| Hikida, Muneo| Kumon, Hiromi| |
Abstract | Ulifloxacin is the active form of the prodrug prulifloxacin and shows a highly potent antipseudomonal activity. In this study, we examined the combined effect of fosfomycin and ulifloxacin against Pseudomonas aeruginosa (P. aeruginosa) growing in a biofilm using a modified Robbins device with artificial urine, and compared it to that of the combination of fosfomycin and ciprofloxacin or levofloxacin. An ATP bioluminescence assay was used to evaluate the antibacterial activity of the agents against sessile cells in a mature biofilm developed on a silicon disk. The total bioactivity of P. aeruginosa growing in a biofilm that had not been fully eradicated by fosfomycin or any of the fluoroquinolones alone at 10 times the MIC decreased after combination treatment with fosfomycin and fluoroquinolones. Morphological changes occurred in a time-dependent fashion; namely, swollen and/or rounding cells emerged within a couple of hours after combination treatment, marking the initial stage in the process leading to the destruction of the biofilms. We could not find any difference among the 3 fluoroquinolones with regard to their synergistic effects when administered with fosfomycin. The combination treatment of fosfomycin and fluoroquinolones with highly potent antipseudomonal activities was effective in eradicating sessile cells of P. aeruginosa in the biofilm and promises to be beneficial against biofilm-associated infectious diseases. |
Keywords | urinary tract infection Pseudomonas aeruginosa biofilm ulifloxacin fosfomycin |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 209 |
End Page | 216 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286954 |
Web of Science KeyUT | 000232835600005 |
JaLCDOI | 10.18926/AMO/31976 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Tokuyama, Eijirou| Nanba, Yuzaburo| Tsutsui, Tetsuya| Kimata, Yoshihiro| Nakatsuka, Mikiya| Koshima, Isao| Saika, Takashi| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | The first case of sex reassignment surgery (SRS) in our hospital was performed in January 2001; as of February, 2005, 4 cases of MTF-SRS had been performed. In the 2 most recent cases, we used penile and scrotal skin flaps to avoid complications. The depth and width of the new vagina was made to be adequate for sexual intercourse. Future attention should be focused on devising a surgical technique that will help prevent the complications of partial necrosis of the epidermal skin and wound dehiscence. Although ours is only an initial experience, we describe our surgical technique herein. |
Keywords | gender identity disorder sex reassignment surgery male to female transsexual |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 231 |
End Page | 233 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286961 |
Web of Science KeyUT | 000232835600008 |
JaLCDOI | 10.18926/AMO/31975 |
---|---|
FullText URL | fulltext.pdf |
Author | Hiraki, Takao| Kanazawa, Susumu| |
Abstract | Hepatic outflow obstruction created by balloon occlusion of the hepatic vein induces characteristic angiographic findings in the occluded area: prolonged enhancement on hepatogram followed by reversed portal opacification on the hepatic arteriogram and perfusion defect on the arterial portogram. The following induced hepatic hemodynamic changes are suggested: hepatic arterial flow increases, and the portal vein acts as a draining vein with slow reversed flow. These unique hemodynamic changes enhance the effect of hepatic interventional therapies. In transcatheter arterial infusion, increasing hepatic arterial flow and absence of portal inflow can bring about a high concentration of drugs, the presence of which is greatly protracted due to outflow blockage. In transcatheter arterial chemoembolization, reversed portal flow can allow portal embolization in addition to arterial embolization. In microwave coagulation therapy and radiofrequency ablation therapy, decreasing portal flow can cause larger areas of coagulation. Further, the technique of hepatic venous occlusion has potential therapeutic applications. |
Keywords | liver hepatic vein obstruction blood supply therapy |
Amo Type | Letter to the Editor |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 171 |
End Page | 178 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286956 |
Web of Science KeyUT | 000232835600001 |
JaLCDOI | 10.18926/AMO/31974 |
---|---|
FullText URL | fulltext.pdf |
Author | Teramoto, Hidefumi| Kawai, Akira| Sugihara, Shinsuke| Yoshida, Aki| Inoue, Hajime| |
Abstract | Apatite-wollastonite containing glass ceramic is considered to be difficult to resorb, but we experienced the disappearance of the porous type of Apatite-wollastonite glass ceramic particles . In this study, the resorption of porous apatite-wollastonite glass-ceramic implanted in the femurs of rabbits was investigated, and the process was compared with beta-tricalcium phosphate, a resorbable ceramics. Porous apatite-wollastonite glass-ceramic (70, 80, and 90% porosity) and beta-tricalcium phosphate (75% porosity) were implanted in the femurs of Japanese white rabbits. Samples were harvested and examined 0, 4, 8, 12, 24 and 36 weeks after implantation. Quantitative analysis of the radiographic and histologic findings was performed with NIH Image software. Radiographic examination demonstrated that the radiopacity and size of the porous apatite-wollastonite glassceramic cylinders decreased gradually after implantation. Histologic examination revealed that the surface area of the apatite-wollastonite glass-ceramic cylinders decreased continuously, and approached 20% of the original area 36 weeks after implantation. However, the resorption rate of porous apatite-wollastonite glass-ceramic was slower than that of beta-tricalcium phosphate. Toluidine blue staining showed abundant new bone formation on the surface of the apatite-wollastonite glassceramic matrix. Considering its mechanical strength, gradual resorption characteristics, and good osteochonductive activity, porous apatite-wollastonite glass-ceramic appears to be a suitable artificial bone substitutes. |
Keywords | apatite-wollastonite containing glass-ceramic (A-W GC) resorption porous ?-tricalcium phosphate(?-TCR) |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 201 |
End Page | 207 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286959 |
Web of Science KeyUT | 000232835600004 |
JaLCDOI | 10.18926/AMO/31973 |
---|---|
FullText URL | fulltext.pdf |
Author | Edamura, Kohei| Saika, Takashi| Senoh, Takashi| Koizumi, Fumihito| Manabe, Daisuke| Ebara, Shin| Kaku, Haruki| Yokoyama, Teruhiko| Abarzua, Fernando| Nagai, Atsushi| Nasu, Yasutomo| Tsushima, Tomoyasu| Kumon, Hiromi| |
Abstract | This study was undertaken to reveal the trends of prostate cancer and the outcome of treatment modalities for each disease stage in patients in a single institute over a 10-year period. From January 1994 through December 2003, 420 consecutive patients with previously untreated and histologically confirmed prostate cancer were analyzed for annual distributions of disease stages and treatment modalities and for long-term clinical progression-free survival, prostate cancer-specific survival, and prostate-specific antigen (PSA) failure-free survival rates for each stage and treatment modality. Annual trends showed that the number of patients, especially those with clinically localized cancer, increased dramatically. The 5-year disease-specific survival rates for patients with clinically localized disease were 100 percent for all treatment modalities, including hormonal therapy alone. Patients with PSA levels less than 10 ng/ml showed an 81 percent 5-year PSA failure-free survival rate with radical prostatectomy. Stage C patients treated by surgery or radiation-based therapy with concomitant hormonal therapy obtained 93 percent and 100 percent cause-specific survival rates, respectively, and those treated by hormonal therapy alone showed a 79 percent rate. The number of patients with localized prostate cancer was increasing in this decade. While long-term hormonal therapy alone was highly efficient in controlling localized prostate cancer, radical therapies in conjunction with neo-adjuvant hormonal therapy produced better survival rates in cases of locally advanced disease. |
Keywords | prostate carcinoma long-term cohort retrospective outcome |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 195 |
End Page | 199 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286958 |
Web of Science KeyUT | 000232835600003 |
JaLCDOI | 10.18926/AMO/31972 |
---|---|
FullText URL | fulltext.pdf |
Author | Hiramatsu, Yuji| Masuyama, Hisashi| Ishida, Makoto| Murakami, Kazuharu| Sakurai, Masaru| |
Abstract | It is well known that antecedent term delivery and metastasis to sites other than the lungs and vagina are high risk factors for patients with gestational trophoblastic neoplasia. Here we report on a patient with choriocarcinoma who presented with brain and lung metastases after term delivery and was treated by EMA-CO chemotherapy. A 31-year-old woman delivered a healthy infant at term. Frequent episodes of hemoptysis occurred beginning 3 weeks after the delivery. On admission to our hospital, she had lesions in the uterus, lungs and brain as well as motor aphasia and hemiplagia. The pretreatment beta-hCG level was 21,000 ng/ml and the WHO score was 16 (high-risk group). The EMA-CO regimen was administrated as first-line chemotherapy and the patient achieved complete remission after 7 courses. Treatment was terminated after 11 courses and maintained with etoposide (25 mg/day) for 6 months. The patient has remained in complete remission for more than 16 years without other adjuvant therapies. We believe that EMA-CO can currently be considered the regimen of first choice for most high-risk patients with gestational trophoblastic neoplasia in view of its effectiveness and excellent tolerability. |
Keywords | choriocarcinoma term delivery EMA-CO chemotherapy metastasis |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 253 |
End Page | 258 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286962 |
Web of Science KeyUT | 000232835600009 |
JaLCDOI | 10.18926/AMO/31971 |
---|---|
FullText URL | fulltext.pdf |
Author | Imabayashi, Kiyomi| Yamamoto, Yuji| Inagaki, Sachiyo| Doi, Yusuke| Yoshitome, Kei| Miyaishi, Satoru| Ishizu, Hideo| |
Abstract | We have improved on conventional methods for HLA-DRB1 genotyping and devised a new method that is simple, cost-effective, and adequately applicable to routine forensic practice. This method consists of group-specific polymerase chain reaction (PCR) of the exon 2 region of the HLA-DRB1 gene and simultaneous detection of single nucleotide polymorphisms (SNPs) at multiple sites using multiplex primer extension reactions. With this method, we successfully detected HLA-DRB1 genotypes from the following materials: the peripheral blood of 142 donors, 6 aged saliva stains of known DRB1 genotype stored for 5-10 years at room temperature, 10 aged bloodstains of unknown DRB1 genotype stored for 29 years at room temperature, and minimal bloodstains and saliva stains from 3 donors of known DRB1 genotypes. Furthermore, we were able to type DRB1 alleles of the minor component in mixed samples at a proportion of 1/1,000 or 1/10,000. In a criminal case, DRB1 alleles detected from mixed bloodstains on a sword found at the scene enabled us to explain the case. This method is expected to be useful for forensic medicine. |
Keywords | HLA-DRB1 genotyping group specific primer single nucleotide polymorphism multiplex primer extension reactions application to mixed samples |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 179 |
End Page | 194 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286957 |
Web of Science KeyUT | 000232835600002 |
JaLCDOI | 10.18926/AMO/31970 |
---|---|
FullText URL | fulltext.pdf |
Author | Sasaki, Kentaro| Senda, Masuo| Ishikura, Takashi| Ota, Haruyuki| Mori, Takeshi| Tsukiyama, Hisashi| Hamada, Masanori| Shiota, Naofumi| |
Abstract | We examined whether ambulatory ability before surgery might influence the post-operative D-dimer level after total hip arthroplasty (THA). One hundred two patients with hip osteoarthritis receiving THA were included in the current study. The patients were all female, and their ages ranged from 45 to 81 (average 65.0 +- 9.3 years). Age, operated side, body mass index (BMI), disease duration before surgery, pre-operative pain evaluated by visual analogue scale (VAS), total cholesterol value, maximal circumference of the lower leg of the operated side, and timed "Up & Go"test (TUG) before surgery, were retrospectively investigated to examine their relationship with D-dimer levels on post-operative day 7. Patients were divided into 2 groups according to the D-dimer value: over 10 microg/ml (Group D), and under (Group N). Patients in group D (N= 52)were older, had a higher BMI, and had less ambulatory ability than patients in group N (N= 50). As age showed a relationship with the D-dimer value on the 7th day and TUG results, patients in the 2 groups were further subdivided into 50's, 60's, and 70's age brackets. In the 50's bracket, patients in group D had higher BMI than patients in group N, but time for TUG was not significantly different. In the 60's and 70's bracket, patients in group D had less ambulatory ability than patients in group N, but the time for TUG was not directly correlated with the D-dimer value. The results suggest that pre-operative low ambulatory ability in patients with osteoarthritis over 60 years might influence the postoperative D-dimer after THA, indicating the potential risk for post-operative deep venous thrombosis. |
Keywords | timed “Up& Go”test D-dimer total hip arthroplasty |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 225 |
End Page | 230 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286960 |
Web of Science KeyUT | 000232835600007 |
JaLCDOI | 10.18926/AMO/31969 |
---|---|
FullText URL | fulltext.pdf |
Author | Piao, Cheng-Yu| Fujioka, Shin-ichi| Iwasaki, Yoshiaki| Fujio, Kozo| Kaneyoshi, Toshihiko| Araki, Yasuyuki| Hashimoto, Kuniaki| Senoh, Tomonori| Terada, Ryo| Nishida, Tomohiro| Kobashi, Haruhiko| Sakaguchi, Kohsaku| Shiratori, Yasushi| |
Abstract | Lamivudine is widely used to treat patients with hepatitis B. However, the outcomes in patients with hepatocellular carcinoma (HCC) treated with lamivudine have not been established. This study was conducted to evaluate the outcomes of lamivudine treatment for patients with HCC using an untreated, matched control group. Thirty patients with controlled HCC orally received lamivudine. As controls, 40 patients with HCC who were not treated with lamivudine and matched for clinical features were selected. The lamivudine-treated and untreated groups were compared with respect to changes in liver function, HCC recurrence, survival, and cause of death. In the lamivudine-treated group, there was significant improvement in the Child-Pugh score at 24 months after starting treatment, while no improvement was observed in the untreated group. There was no significant difference in the cumulative incidence of HCC recurrence and survival between the groups. However, there was a significant difference in the cumulative incidence of death due to liver failure (P= 0.043). A significant improvement in liver function was achieved by lamivudine treatment, even in patients with HCC. These results suggest that lamivudine treatment for patients with HCC may prevent death due to liver failure. Further prospective randomized studies using a larger number of patients are required. |
Keywords | liver failure Child-Pughscore recurrence survival resistant mutant |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 217 |
End Page | 224 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286955 |
Web of Science KeyUT | 000232835600006 |
JaLCDOI | 10.18926/AMO/31968 |
---|---|
FullText URL | fulltext.pdf |
Author | Win, Ne| Lwin, Aye Aye| Oo, Myat Mon| Aye, Khin Saw| Soe, Soe| Okada, Shigeru| |
Abstract | The population of Myanmar comprises 8 major indigenous races (Bamar, Kayin, Kachin, Shan, Rakhine, Mon, Chin, and Kayah). The Bamar reside in the 7 central divisions of the country, and the others reside in the 7 peripheral states that border neighboring countries, including China, Laos, and Thailand in the east and India and Bangladesh in the west. Both malaria and HbE are endemic in Myanmar, although the actual prevalence of the latter in the different indigenous races is not yet known. Hemoglobin electrophoresis was performed in 4 malaria-endemic villages, each having a different predominating indigenous race. The overall prevalence of HbE was 11.4% (52/456 villagers), ranging from 2-6% in the Kayin-predominant villages to 13.1-24.4% in the Bamar-predominant villages. Although the overall HbE prevalence in the villages studied was not significantly different from that of the general Myanmar population, this study strongly documented the influence of racial differences on the prevalence of HbE in Myanmar. To prevent and control severe thalassemia syndromes in Myanmar, extensive prevalence studies of the country?s indigenous races are suggested. |
Keywords | hemoglobin E malaria indigenous races border areas Myanmar |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-04 |
Volume | volume59 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 63 |
End Page | 66 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049557 |
Web of Science KeyUT | 000228590000005 |
JaLCDOI | 10.18926/AMO/31967 |
---|---|
FullText URL | fulltext.pdf |
Author | Kurtoglu, Zeliha| Ozturk, Ahmet Hakan| Bagdatoglu, Celal| Polat, Gurbuz| Aktekin, Mustafa| Uzmansel, Deniz| Camdeviren, Handan| Bagdatoglu, Ozlen| Sargon, Mustafa| |
Abstract | In this study, we evaluated the effects of trapidil on crush injury by monitoring nitric oxide, malondialdehyde and transforming growth factor-Beta2 levels and by transmission electron microscopy in the rat sciatic nerve. The sciatic nerve was compressed for 20 sec by using a jewelers forceps. Trapidil treatment groups were administrated a single dose of trapidil (8 mg/kg) intraperitoneally just after the injury. The crush and crush + trapidil treatment groups were evaluated on the 2nd, 7th, 15th, 30th and 45th days of the post-crush period. On the 7th and 15th days, damage in thin and thick myelinated axons, endoneural edema and mitochondrial swelling were less severe in the trapidil group histopathologically. These findings supported the idea that trapidil prevented cell damage and edema at the injury site. Day/group interaction with regard to serum nitric oxide, malondialdehyde and transforming growth factor-Beta2 levels did not show significant changes. |
Keywords | trapidil crush injury peripheral nerve electron microscopy nitric oxide |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-04 |
Volume | volume59 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 37 |
End Page | 44 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049553 |
Web of Science KeyUT | 000228590000001 |